Results

1–2 of 2 results for OAKS and DERBY

Safety of Intravitreal Pegcetacoplan for Geographic Atrophy: 12-Month Results of the OAKS and DERBY Trials
Caroline Baumal, MD, FASRS
Annual Meeting Talks
2022
Detailed Baseline Demographics and Disease Characteristics of Patients With Geographic Atrophy Enrolled in the Phase 3 OAKS and DERBY Clinical Trials
On Demand Cases, Courses, and Papers
2022